Should You Buy Hinge Health After the HNGE Stock IPO?

Investing in companies that have recently gone public is a strategy for individuals with a higher risk appetite. Typically, companies list on an exchange via an initial public offering to raise money and fund their expansion plans. So, while investors can “get in early” and be part of a company’s growth story, you also need to be ready for a volatile ride at least in the first few years. 

Hinge Health (HNGE), a health-tech platform that went public last week, is valued at $3.35 billion. It develops healthcare software for joint and muscle health. The platform is designed to address musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. Many refer to these offerings as “digital physical therapy.” It also provides various administrative and operational support services.